Transactions
May 14, 2002
INVESTORS POUR FUNDING INTO CAMBRIDGE COMPANY
Biopure Corp. closed its public offering of 2.7 million shares on April 24. The deal brought in $20.7 million for the company. The sole underwriter was Sausalitio's Shoreline Pacific.
The sole underwriter was Sausalitio's Shoreline Pacific.
Cambridge, Mass.'s Biopure makes and sells products that deliver oxygen to cells through the boodstream. Its signature products are Hemopure,...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In